Colin Winston Gillis

Colin Winston Gillis, PharmD, MBA has extensive experience in regulatory affairs and strategy in the pharmaceutical industry. Colin Winston is currently a Senior Director of Regulatory Strategy at Beam Therapeutics, where they have been working since 2022. Prior to that, they worked at Biogen for several years in various roles, including Associate Director of US Regulatory Sciences and Senior Manager of US Regulatory Affairs. Colin Winston also served as an Adjunct Assistant Professor at MCPHS University and worked as a Regulatory Development Intern at Biogen Idec. Overall, Gillis has a strong background in regulatory affairs and has made significant contributions in this field throughout their career.

Colin Winston Gillis earned a Doctor of Pharmacy (PharmD) degree from Northeastern University, where they studied pharmacy from 2007 to 2015. In 2022, they graduated from Babson F.W. Olin Graduate School of Business with a Master of Business Administration (MBA) degree.